nyse cbm industry pharmaceuticals founded new jersey 1981 headquarters east rutherford nj key people steven m. klosk ceo president gregory p. sargen cfo executive vp shawn p. cavanagh coo executive vp samantha m. hanley general counsel and corporate secretary aldo magnini managing director cambrex profarmaco milano revenue 433.9 million usd 2015 net income 57.2 million usd 2015 total assets 505.5 million usd 2015 total equity 310.8 million usd 2015 number of employees 1 200 slogan innovation . experience . performance . website www.cambrex.com cambrex corporation is a global innovative life sciences company that provides products and services to accelerate the development and commercialization of small molecule active pharmaceutical ingredients apis . cambrex has cgmp manufacturing facilities in the us charles city ia europe karlskoga sweden milan italy and hyderabad india and r & d centers in tallinn estonia wiesbaden germany . the headquarters are located in east rutherford nj . in 2007 cambrex divested their biologics business to lonza to focus on small molecule apis . contents 1 history 2 products and services 2.1 custom api manufacturing 2.2 generic apis and intermediates 2.3 drug product formulations 3 specialized api services 3.1 controlled substances 3.2 highly potent compounds 3.3 high energy chemistry 3.4 biocatalysis 4 references 5 external links history edit cambrex was founded in 1981 when the caschem group acquired the castor oil and derivatives product lines from nl industries . in 1987 caschem was renamed cambrex corporation and became listed on nasdaq . cambrex entered the pharmaceutical market in 1994 with the acquisition of nobel pharma chemistry business now known as cambrex karlskoga ab and cambrex profarmaco . through multiple acquisitions during the late 1990s cambrex entered the bioscience and the chiral enzymatic catalyst markets . in 1998 cambrex was listed on the nyse . cambrex acquired two contract biopharmaceutical manufacturing facilities in 2001 to bulk manufacture biologics and pharmaceutical ingredients from clinical to commercial scales . in 2007 cambrex decided to focus on its core competencies and sold the biologics business to lonza group . in 2008 prosyntest now cambrex tallinn was acquired and steve klosk was appointed ceo while remaining president . to broaden their biocatalysis platform cambrex acquired iep now known as cambrex iep . in 2014 cambrex acquired zenara pharma to enhance its drug product formulation capabilities including nicotine replacement therapy products.cambrex corporation has agreed to acquire pharma core inc a private company specializing in developing manufacturing and scaling up small molecule apis for clinical phase projects for approx 25 million 1 products and services edit custom api manufacturing edit cambrex offers custom api development and manufacturing services for toxicology studies clinical studies and for commercial supply . route selection development and optimization process and analytical development and validation safety and toxicology assessments stability methods and testing analytical method development and validation cgmp kilo and pilot plans cgmp commercial production scale up and tech transfer regulatory filing support generic apis and intermediates edit cambrex commercially supplies over 100 generic apis and intermediates for the pharmaceutical and biotechnology industries.cambrex provides european and us intellectual property rights evaluations and early development work using non patent infringing processes . drug product formulations edit cambrex provides product development and manufacturing services for solid oral dosage forms including nicotine replacement therapy . tablets capsules gums lozenges specialized api services edit controlled substances edit us dea schedule ii v development and manufacturing distribution and importation licenses over 20 drug master files highly potent compounds edit cytotoxic and cytostatic development and manufacturing to 1 ug m3 oel toxicology to commercial quantities dedicated development lab and resources high energy chemistry edit remote controlled emp production facility hazardous material process lab testing to ensures safe handling m storage and transport continuous and batch reaction processes biocatalysis edit enzyme screening with proprietary library route scouting process development and enzyme manufacture manufacture of chiral products apis or intermediates references edit cambrex to acquire api manufacturer in us . worldofchemicals . sep 30 2016 . retrieved september 30 2016 . external links edit cambrex website zenara website product list 1 brochure 2 retrieved from https en.wikipedia.org w index.php title cambrex corporation & oldid 742114994 categories companies listed on the new york stock exchangepharmaceutical companies based in new jerseypharmaceutical companies of the united states navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages add links this page was last modified on 1 october 2016 at 20 14 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view